Taking people in GreeceNo phase
Two immune-calming drugs, with or without an anti-scarring drug, for scleroderma lung disease
Observes adults with scleroderma lung disease on two immune drugs, with or without anti-scarring medicine.
Plain-language title generated from the registry record
Registry title: Double Immunosuppression With or Without Anti-fibrotic in Scleroderma ILD
Key facts
- Where
- Pátrai, GreeceSee the site
Where in Greece
- University of PatrasPátrai, GreeceTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University of Patras
- Trial code
- NCT07491523
- Record updated
- 24 March 2026
- Original description
Patients with ssc-ild receiving double immunosuppression with or without anti fibrotic tratmentRead full original descriptionShow less
Double Immunosuppression With or Without Anti-fibrotic in Scleroderma ILD
Patients with ssc-ild receiving double immunosuppression with or without anti fibrotic tratment
Inclusion: -.
Exclusion: ssc without ild.